We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
+8.44%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$448M
AUM Growth
-$12.7M
Cap. Flow
-$38.5M
Cap. Flow %
-8.59%
Top 10 Hldgs %
34.14%
Holding
118
New
16
Increased
20
Reduced
42
Closed
17

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$14.3M
2
ANET icon
Arista Networks
ANET
+$8.93M
3
VEEV icon
Veeva Systems
VEEV
+$8.79M
4
AMT icon
American Tower
AMT
+$7.18M
5
CTSH icon
Cognizant
CTSH
+$6.82M

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$13.2M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$11.1M
3
WP
Worldpay, Inc.
WP
+$10.7M
4
MKSI icon
MKS Inc
MKSI
+$9.33M
5
DHR icon
Danaher
DHR
+$8.53M

Sector Composition

Rank Sector Weight
1 Technology 30.09%
2 Healthcare 22.25%
3 Industrials 10.91%
4 Consumer Discretionary 10.09%
5 Communication Services 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMT icon
26
American Tower
AMT
$77.1B
$7.41M 1.65%
+56,020
New +$7.18M
MAN icon
27
ManpowerGroup
MAN
$2.38B
$7.19M 1.6%
64,400
+2,600
+4% +$268K
MDSO
28
DELISTED
Medidata Solutions, Inc.
MDSO
$6.71M 1.5%
+85,800
New +$5.98M
MKSI icon
29
MKS Inc
MKSI
$23.4B
$6.58M 1.47%
97,850
-123,150
-56% -$9.33M
ROP icon
30
Roper Technologies
ROP
$33.9B
$5.79M 1.29%
+25,000
New +$5.53M
XL
31
DELISTED
XL Group Ltd.
XL
$5.18M 1.16%
+118,400
New +$4.99M
UNH icon
32
UnitedHealth
UNH
$392B
$5.02M 1.12%
+27,100
New +$4.75M
SHW icon
33
Sherwin-Williams
SHW
$79B
$4.75M 1.06%
+40,650
New +$4.54M
OC icon
34
Owens Corning
OC
$11.3B
$4.71M 1.05%
+70,350
New +$4.41M
HSIC icon
35
Henry Schein
HSIC
$9.63B
$4.54M 1.01%
63,291
-1,505
-2% -$105K
FBIN icon
36
Fortune Brands Innovations
FBIN
$5.98B
$4.52M 1.01%
+81,023
New +$4.39M
TMUS icon
37
T-Mobile US
TMUS
$206B
$3.64M 0.81%
60,050
-109,100
-64% -$7.11M
SCHW
38
Charles Schwab
SCHW
$174B
$3.16M 0.7%
73,500
-120,800
-62% -$4.84M
SBUX icon
39
Starbucks
SBUX
$118B
$2.86M 0.64%
49,100
-6,200
-11% -$375K
TMO icon
40
Thermo Fisher Scientific
TMO
$195B
$2.77M 0.62%
15,900
-150
-0.9% -$25.2K
ILMN icon
41
Illumina
ILMN
$28.9B
$2.65M 0.59%
15,677
ABBV icon
42
AbbVie
ABBV
$447B
$2.59M 0.58%
35,675
+125
+0.4% +$8.4K
DHR icon
43
Danaher
DHR
$127B
$2.57M 0.57%
34,348
-113,928
-77% -$8.53M
ALXN
44
DELISTED
Alexion Pharmaceuticals
ALXN
$2.5M 0.56%
20,550
-400
-2% -$46.6K
AZTA icon
45
Azenta
AZTA
$1.24B
$2.38M 0.53%
+109,900
New +$2.78M
BRK.B icon
46
Berkshire Hathaway Class B
BRK.B
$1.05T
$2.35M 0.53%
13,900
-66,450
-83% -$11.1M
MASI
47
DELISTED
Masimo
MASI
$2.3M 0.51%
25,250
EW icon
48
Edwards Lifesciences
EW
$48.5B
$2.25M 0.5%
57,000
GILD icon
49
Gilead Sciences
GILD
$162B
$2.24M 0.5%
31,675
-500
-2% -$33.3K
ATO icon
50
Atmos Energy
ATO
$29.6B
$2.11M 0.47%
25,400

Similar funds

De Burlo Group's Q2 2017 Portfolio in Review

As of Q2 2017, De Burlo Group held 118 positions worth $448M, down 2.8% from $461M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

De Burlo Group withdrew a net $38.5M in Q2 2017, closing 17 positions and reducing 42 holdings. Its most notable exit was IBM, an estimated $13.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, De Burlo Group opened a new position in Arista Networks worth $9.23M.

  • De Burlo Group's largest Q2 2017 buy was Arista Networks: 985,920 shares worth $9.23M.
  • De Burlo Group added most to Salesforce in Q2 2017, an estimated $14.3M increase.
  • De Burlo Group's biggest Q2 2017 reduction was Berkshire Hathaway Class B, cutting an estimated $11.1M.
  • De Burlo Group fully exited IBM in Q2 2017, selling an estimated $13.2M.
  • De Burlo Group's ten largest holdings make up 34% of its $448M portfolio in Q2 2017.
  • De Burlo Group opened 16 new positions and closed 17 in Q2 2017.
  • De Burlo Group's portfolio value fell 2.8% quarter-over-quarter to $448M.

Based on De Burlo Group's 13F filing for Q2 2017, filed 3 Aug 2017.